Please login to the form below

Not currently logged in
Email:
Password:

New member for Millennium Pharmaceuticals board

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Dr Leiden, currently managing director at life sciences venture capital firm, Clarus Ventures, has over 20 years of experience in the biomedical and pharmaceutical sectors.

Prior to joining Clarus, Leiden served as President and COO of the global Pharmaceutical business of US pharmaceutical company, Abbott Laboratories.

Before joining Abbott in 2000, Leiden was the Elkan R Blout professor of biological sciences at Harvard School of Public Health, as well as professor of medicine at Harvard Medical School. Before his career at Harvard, he served as professor of medicine and pathology and chief of cardiology at the University of Chicago, School of Medicine. Leiden has also co-founded several biotechnology firms.

"It is a pleasure to have Dr Leiden join the Millennium Board of Directors," said Deborah Dunsire, Millennium's CEO, "We believe his diverse pharmaceutical and scientific experience will enable him to help guide our continued growth and success in our mission of delivering vital medicines to patients."

Leiden joins as an independent director and brings the number of Millennium board members to ten.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....
fig 1 DARWINS MEDICINE
Back to the future
Five years ago, an influential book used Darwin’s ideas to predict the future of the industry – how did that work out?...
Rare Disease Day 2021
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to...

Infographics